Abilify Tab 10 mg (Aripiprazole (Micronized))

Adult dose

Adults with schizophrenia: Start at 10 mg or 15 mg once daily, with adjustment possible within a dose range of 10-30 mg once daily, regardless of meals. Maintenance treatment is administered at a dose of 15 mg once daily for at least 3 months. Adults with bipolar disorder: Start at 15 mg once daily as monotherapy or adjunct therapy, with a maximum increase up to 30 mg once daily. Adjunctive treatment for major depressive disorder: 2-5 mg once daily,

Child dose

Adolescents with schizophrenia (13-17 years): The recommended dose is 10 mg once daily, with an initial dose of 2 mg, increasing to 5 mg and then to 10 mg, with further increases in 5 mg increments. Bipolar disorder

This medication may increase the risk of suicidal thoughts or behavior in children, adolescents, and young adults with major depressive disorder or psychiatric disorders, so a doctor must carefully evaluate the necessity and risks before use. Patients of all ages should be closely monitored for changes in suicidal tendencies or behavior after starting treatment, and family or caregivers should also closely observe the patients. This medication is not approved for the treatment of pediatric depression, and in patients with bipolar disorder, manic or mixed episodes may occur, so the presence of bipolar disorder should be confirmed prior to use. While taking this medication, serious side effects known as Neuroleptic Malignant Syndrome may occur, and if symptoms such as high fever, muscle rigidity, or altered mental status occur, immediate medical attention is necessary. Long-term use may lead to tardive dyskinesia, an irreversible neurological condition, so it is recommended to use the minimum effective dose for the shortest duration. In elderly patients with dementia, the risk of cerebrovascular accidents such as strokes and mortality may increase, so it is advisable not to use it in this population. Since it may affect blood sugar control, diabetic patients or those at risk of hyperglycemia should regularly monitor their blood glucose levels. Due to the risk of venous thromboembolism, patients with risk factors for thrombosis should be closely monitored before and during administration. This medication should not be administered to patients with previous allergic reactions or lactose intolerance. Caution is advised while driving or operating dangerous machinery for patients with orthostatic hypotension, history of seizures, or impaired judgment or motor ability. Care should also be taken in patients with temperature regulation disorders or dysphagia. This medication can cause side effects such as drowsiness, insomnia, anxiety, headache, vomiting, constipation, and patients should consult with a doctor if abnormal movement symptoms or mental changes occur. In particular, close observation of side effects and unusual behaviors is important, especially at the beginning of treatment or when doses are changed.

Serious side effects

Urticaria, itching, severe swelling (angioedema), difficulty breathing (dyspnea), cold sweat, pallor, severe allergic reactions, severe rashes with fever, blisters, skin peeling, mucosal pain in the mouth/eyes, severe skin abnormal reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory distress accompanied by cough and fever, jaundice of the skin or eyes, extreme lethargy, liver abnormalities (jaundice), sudden and very severe changes

Mild side effects

• Nausea
• vomiting
• constipation
• headache
• dizziness
• akathisia
• anxiety
• insomnia
• restlessness
• drowsiness

This medication should be stored in a tightly closed container to protect it from air and moisture, preferably at a cool room temperature between 1°C and 30°C. Storing it this way will help maintain the medication's effectiveness for a longer time.

Appearance

Pink rectangular tablet

Package unit

30 tablets/bottle, 100 tablets/bottle